Renaissance Bioscience has patented pioneering RNA production and delivery technologies in China

Renaissance Bioscience Corp., a global bioengineering leader in agriculture, animal health, human medicine and food, announced that it has been granted a patent from the Chinese Patent Office. The patent, the first for its innovative yeast-based technology for the production and delivery of RNA bioactive molecules, enriches and expands Renaissance Bioscience's strong intellectual property portfolio, which includes 50 patents and 11 pending applications worldwide. Given that China is the world's largest pesticide consumer and a leading biopesticide producer, this patent is significant.

 This advanced yeast platform technology is expected to transform the global agricultural industry through its precise, targeted approach to pest control. In addition, the impact goes far beyond this, the technology also has high application prospects in the field of animal health and human medicine.

Dr. John Husnik, Chief Scientific Officer of Renaissance Bioscience, expressed his enthusiasm: "This groundbreaking patent granted in China strengthens our position as a global innovator in RNA technology. As our patent portfolio expands, we expect to open up numerous opportunities not only in China, but also internationally.

Key benefits of Renaissance Bioscience's yeast-based RNA technology include: 

1. Stability: The toughness of yeast ensures that RNA molecules are protected in different environments.  

2. Manufacturing: Economical, scalable and quality-oriented yeast production means cost-effective manufacturing of RNA bioactive molecules.  

3. Adaptability: The platform's versatility supports multi-gene targeting and compound integration, extending its applicability.  

4. Safety: The use of inactivated food-grade bread yeast ensures safety, paving the way for smoother regulatory approvals

Biopesticides from Renaissance Bioscience use RNA interference (RNAi) to selectively inhibit proteins critical to the development of target pests. This targeted approach aims to maintain the specific effects of RNAi on its intended target in order to protect the health of other organisms. In addition, its biodegradability ensures no impact on the environment.

About Renaissance Bioscience Corp. 

Vancouver-based Renaissance Bioscience is at the forefront of innovation in microbial bioengineering. Their pioneering technologies are shaping the future of a variety of industries, from agriculture, food and beverage to health and energy.